ATE465715T1 - Orales abgabesystem mit einem biliquid foam - Google Patents
Orales abgabesystem mit einem biliquid foamInfo
- Publication number
- ATE465715T1 ATE465715T1 AT04767956T AT04767956T ATE465715T1 AT E465715 T1 ATE465715 T1 AT E465715T1 AT 04767956 T AT04767956 T AT 04767956T AT 04767956 T AT04767956 T AT 04767956T AT E465715 T1 ATE465715 T1 AT E465715T1
- Authority
- AT
- Austria
- Prior art keywords
- weight
- biliquid foam
- delivery system
- oral delivery
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0317869.6A GB0317869D0 (en) | 2003-07-30 | 2003-07-30 | Improved drug delivery system |
| PCT/GB2004/003329 WO2005011628A2 (en) | 2003-07-30 | 2004-07-30 | Oral delivery system comprising a biliquid foam |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE465715T1 true ATE465715T1 (de) | 2010-05-15 |
Family
ID=27799499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04767956T ATE465715T1 (de) | 2003-07-30 | 2004-07-30 | Orales abgabesystem mit einem biliquid foam |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060228408A1 (de) |
| EP (1) | EP1653923B1 (de) |
| JP (1) | JP4953815B2 (de) |
| CN (2) | CN1832727A (de) |
| AT (1) | ATE465715T1 (de) |
| AU (1) | AU2004261053B2 (de) |
| CA (1) | CA2533833C (de) |
| DE (1) | DE602004026879D1 (de) |
| DK (1) | DK1653923T3 (de) |
| ES (1) | ES2344898T3 (de) |
| GB (1) | GB0317869D0 (de) |
| RU (1) | RU2353350C2 (de) |
| WO (1) | WO2005011628A2 (de) |
| ZA (1) | ZA200600761B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0404403D0 (en) | 2004-02-27 | 2004-03-31 | Disperse Ltd | Dispersions |
| US10265265B2 (en) | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
| EP2008651A1 (de) | 2007-06-26 | 2008-12-31 | Drug Delivery Solutions Limited | Biologisch erodierbares Patch |
| GB0712389D0 (en) * | 2007-06-26 | 2007-08-01 | Drug Delivery Solutions Ltd | A Pharmaceutical composition |
| CN101780037B (zh) * | 2010-02-03 | 2011-11-16 | 南昌大学 | 双嘧达莫自乳化给药系统及其制备方法 |
| GB201006218D0 (en) | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
| ES2736256T3 (es) | 2011-03-14 | 2019-12-27 | Drug Delivery Solutions Ltd | Composición oftálmica |
| JP6067676B2 (ja) * | 2011-04-11 | 2017-01-25 | アヤンダ グループ エーエス | 経口医薬分散組成物 |
| EP3542788A1 (de) | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4486333A (en) * | 1981-04-10 | 1984-12-04 | Felix Sebba | Preparation of biliquid foam compositions |
| US4999198A (en) * | 1989-03-23 | 1991-03-12 | The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations | Polyaphrons as a drug delivery system |
| US5840881A (en) * | 1992-11-27 | 1998-11-24 | Takeda Chemical Industries, Ltd. | Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility |
| WO1997032559A1 (en) * | 1996-03-08 | 1997-09-12 | Disperse Technologies Limited | Dispersions comprising an oil-based biliquid foam and an aqueous gel |
| NL1003503C2 (nl) * | 1996-07-04 | 1998-01-07 | Negma Steba International Dev | Farmaceutische samenstelling voor orale toediening. |
| GB2326337A (en) * | 1997-06-20 | 1998-12-23 | Phares Pharma Holland | Homogeneous lipid compositions for drug delivery |
| CA2368334C (en) * | 2000-02-22 | 2010-04-20 | Color Access, Inc. | Acidic gelled aqueous cosmetic compositions comprising oil-containing biliquid foam dispersion |
| GB0214793D0 (en) * | 2002-06-26 | 2002-08-07 | Disperse Technologies Plc | Biliquid foam entrapment |
-
2003
- 2003-07-30 GB GBGB0317869.6A patent/GB0317869D0/en not_active Ceased
-
2004
- 2004-07-30 CN CNA2004800223841A patent/CN1832727A/zh active Pending
- 2004-07-30 DE DE602004026879T patent/DE602004026879D1/de active Active
- 2004-07-30 CA CA2533833A patent/CA2533833C/en active Active
- 2004-07-30 AU AU2004261053A patent/AU2004261053B2/en not_active Ceased
- 2004-07-30 CN CN2009101468709A patent/CN101579311B/zh active Active
- 2004-07-30 WO PCT/GB2004/003329 patent/WO2005011628A2/en active Search and Examination
- 2004-07-30 AT AT04767956T patent/ATE465715T1/de not_active IP Right Cessation
- 2004-07-30 US US10/566,209 patent/US20060228408A1/en not_active Abandoned
- 2004-07-30 DK DK04767956.8T patent/DK1653923T3/da active
- 2004-07-30 ZA ZA200600761A patent/ZA200600761B/en unknown
- 2004-07-30 ES ES04767956T patent/ES2344898T3/es active Active
- 2004-07-30 EP EP04767956A patent/EP1653923B1/de active Active
- 2004-07-30 RU RU2006106173/15A patent/RU2353350C2/ru active
- 2004-07-30 JP JP2006521672A patent/JP4953815B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200600761B (en) | 2007-05-30 |
| WO2005011628A2 (en) | 2005-02-10 |
| WO2005011628A3 (en) | 2005-05-06 |
| JP2007500181A (ja) | 2007-01-11 |
| DK1653923T3 (da) | 2010-08-09 |
| JP4953815B2 (ja) | 2012-06-13 |
| RU2353350C2 (ru) | 2009-04-27 |
| ES2344898T3 (es) | 2010-09-09 |
| US20060228408A1 (en) | 2006-10-12 |
| CA2533833C (en) | 2013-05-28 |
| AU2004261053B2 (en) | 2011-08-25 |
| GB0317869D0 (en) | 2003-09-03 |
| CN101579311A (zh) | 2009-11-18 |
| EP1653923A2 (de) | 2006-05-10 |
| CN1832727A (zh) | 2006-09-13 |
| EP1653923B1 (de) | 2010-04-28 |
| CN101579311B (zh) | 2013-11-27 |
| AU2004261053A1 (en) | 2005-02-10 |
| DE602004026879D1 (de) | 2010-06-10 |
| CA2533833A1 (en) | 2005-02-10 |
| RU2006106173A (ru) | 2007-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005115406A3 (en) | 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents | |
| WO2005112633A3 (en) | Compounds and compositions for delivering active agents | |
| WO2007008752A3 (en) | Sustained release pharmaceutical compositions for highly water soluble drugs | |
| CY1111458T1 (el) | Μορφες δοσολογιας γενικως γραμμικης, αναβραζουσας, απο του στοματος φεντανυλης και μεθοδοι χορηγησης | |
| ATE493973T1 (de) | Irbesartan enthaltende pharmazeutische zusammensetzung | |
| WO2005089729A3 (en) | Galenic formulations of organic compounds | |
| WO2006035417A3 (en) | Dihydropyrimidine microcapsule - formulations | |
| WO2008060934A8 (en) | Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration | |
| BR0112311A (pt) | Compostos e composições para liberar agentes ativos, forma de dosagem unitária, método para preparar ditas composições e seu uso | |
| NO20063429L (no) | Brusende oral opiat doseringsform | |
| WO2002019969A3 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
| AR108594A2 (es) | Formulaciones farmacéuticas que conservan el sabor con características farmacéuticas mejoradas | |
| NO20062051L (no) | Farmasoytisk virkestoffinneholdende formulering med belegg | |
| AR052252A1 (es) | Formulaciones topicas de nepafenac | |
| MXPA05008909A (es) | Formulacion intranasal de rotigotina. | |
| SG147450A1 (en) | Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof | |
| WO2008023016A3 (en) | Galenic formulations of aliskiren | |
| NO20056241L (no) | Nanopartikler av polyoksyetylenerte derivater | |
| WO2006053089A3 (en) | Methods and formulations for making pharmaceutical compositions containing bupropion | |
| ATE465715T1 (de) | Orales abgabesystem mit einem biliquid foam | |
| WO2008056375A3 (en) | Pharmaceutical formulations comprising valsartan | |
| WO2002034240A3 (en) | Delayed and sustained release formulations and method of use thereof | |
| JP2007500181A5 (de) | ||
| EA200600953A1 (ru) | Дозированные формы торсемида пролонгированного высвобождения | |
| DE60309472D1 (de) | Pharmazeutische formulierung mit einem nichtpeptidischen renin-hemmer und surfactant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |